Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable
prognosis. Here we summarize the knowledge about diagnosis, epidemiology …

Context: Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy with
incompletely understood pathogenesis and poor prognosis. Patients present with hormone …

AACE= American Association of Clinical Endocrinologists; AAES= American Association of
Endocrine Surgeons; ACC= adrenocortical carcinoma; ACE= angiotensin-converting …

Adrenocortical carticnoma (ACC) is a rare malignancy with an incidence of 0.7–2.0
cases/million habitants/year. The diagnosis of malignancy relies on careful investigations of …

Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy, and most of the
diagnostic and therapeutic strategies are not fully established according to criteria of …

BACKGROUND: The role of laparoscopic adrenalectomy in the treatment of patients with
adrenocortical carcinoma (ACC) is controversial. OBJECTIVE: Our aim was to compare …

OBJECTIVE. Adrenocortical carcinoma (ACC) is a rare, aggressive tumor arising from the
adrenal cortex that typically presents late with a large mass. The increased use of cross …

In the last decades, minimally invasive transperitoneal laparoscopic adrenalectomy has
become the standard of care for surgical resection of the adrenal gland tumors. Recently …

Background Complete surgical resection is the mainstay of treatment for patients with
adrenocortical cancer (ACC). Use of laparoscopy has been questioned in patients with ACC …

Laparoscopic adrenalectomy (LA) was first described in the literature in 1992, and has
become the preferred method for the removal of benign functioning and non-functioning …